Description: Pharmaceutical preparations for use in cancer, tumors, diabetic kidney disease, coronary microvascular dysfunction, Buerger's Disease, and Critical Limb Ischemia; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology, cardiology, vascular system, and ischemia; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for promoting ischematic repair, regenerating damaged tissue, stimulating the repair or growth of microvasculature, penetrating tissue surrounding tumors, and altering immunosuppressive tumor microenvironments; Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Drug discovery services
